Search Results1-15 of  15

  • Esaki Taito ID: 9000329006949

    Articles in CiNii:1

    • Subgroup analyses of the safety and efficacy of ramucirumab in Japanese and Western patients in RAINBOW : a randomized clinical trial in second-line treatment of gastric cancer (2016)
  • Esaki Taito ID: 9000390405292

    Articles in CiNii:1

    • Irinotecan monotherapy as third-line or later treatment in advanced gastric cancer (2018)
  • Esaki Taito ID: 9000398029931

    Articles in CiNii:1

    • First-line chemotherapy with S-1 alone or S-1 plus cisplatin for elderly patients with advanced gastric cancer : a multicenter propensity score matched study (2018)
  • Esaki Taito ID: 9000399574889

    Articles in CiNii:1

    • Peritoneal metastasis as a predictive factor for nab-paclitaxel in patients with pretreated advanced gastric cancer : an exploratory analysis of the phase Ⅲ ABSOLUTE trial (2019)
  • Esaki Taito ID: 9000401420826

    Articles in CiNii:1

    • A subanalysis of Japanese patients in a randomized, double-blind, placebo-controlled, phase 3 trial of nivolumab for patients with advanced gastric or gastro-esophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2) (2019)
  • Esaki Taito ID: 9000403259784

    Articles in CiNii:1

    • Phase 1 trial of avelumab (anti-PD-L1) in Japanese patients with advanced solid tumors, including dose expansion in patients with gastric or gastroesophageal junction cancer : the JAVELIN Solid Tumor JPN trial (2019)
  • Esaki Taito ID: 9000403925325

    Articles in CiNii:1

    • Propensity Score Analysis of Regorafenib Versus Trifluridine/Tipiracil in Patients with Metastatic Colorectal Cancer Refractory to Standard Chemotherapy (REGOTAS): A Japanese Society for Cancer of the Colon and Rectum Multicenter Observational Study (2018)
  • Esaki Taito ID: 9000404145808

    Articles in CiNii:1

    • Hypoalbuminemia for the prediction of venous thromboembolism and treatment of direct oral anticoagulants in metastatic gastric cancer patients (2019)
  • ESAKI Taito ID: 9000000386545

    Fukuoka Teishin Hospital (1997 from CiNii)

    Articles in CiNii:1

    • Plasma Adrenal Androgens in Adult Diabetic Men (1997)
  • ESAKI Taito ID: 9000001427958

    Department of Medical Oncology, National Kyushu Cancer Center (2005 from CiNii)

    Articles in CiNii:1

    • Team Approach to Providing the Multidisciplinary Medical Treatment Derived by the Patients and Their Family (2005)
  • ESAKI Taito ID: 9000018235493

    Gastrointestinal Oncology Division, National Kyushu Cancer Center (2010 from CiNii)

    Articles in CiNii:2

    • Oxaliplatin-induced allergic reaction in patients with colorectal cancer in Japan (2009)
    • Phase I/II study of a 3-week cycle of irinotecan and S-1 in patients with advanced colorectal cancer (2010)
  • ESAKI Taito ID: 9000019061385

    Department of Gastrointestinal and Medical Oncology, National Kyushu Cancer Center (2011 from CiNii)

    Articles in CiNii:1

    • Genotype-directed, dose-finding study of irinotecan in cancer patients with UGT1A1^*28 and/or UGT1A1^*6 polymorphisms (2011)
  • Esaki Taito ID: 9000256598376

    Fukuoka Teishin Hospital (1997 from CiNii)

    Articles in CiNii:1

    • Plasma Adrenal Androgens in Adult Diabetic Men. (1997)
  • Esaki Taito ID: 9000257909815

    Department of Medical Oncology, National Kyushu Cancer Center (2005 from CiNii)

    Articles in CiNii:1

    • Team Approach to Providing the Multidisciplinary Medical Treatment Derived by the Patients and Their Family (2005)
  • Taito Esaki ID: 9000403102777

    Articles in CiNii:1

    • Phase II trial of aflibercept with FOLFIRI as a second‐line treatment for Japanese patients with metastatic colorectal cancer (2019)
Page Top